Go Back Go Back
Go Back Go Back
Go Back Go Back

Frequently Asked Questions about DMPA (Depot Medroxy Progesterone Acetate)

Frequently Asked Questions about DMPA (Depot Medroxy Progesterone Acetate)
Frequently Asked Questions about DMPA (Depot Medroxy Progesterone Acetate)

Publisher

Number of pages

16

Author

UNFPA

Publication

Frequently Asked Questions about DMPA (Depot Medroxy Progesterone Acetate)

Publication date

11 November 2018

Download Icon

The Governement of India introduced three new contraceptives in its public health system in 2016. UNFPA India has been assisting the Government of India in roll out of new contraceptives, including injectable contraceptives, and in ensuring high quality services. This publication has been developed to address the questions frequently asked by health providers and managers on injectable contraceptives (DMPA). The questions contained in this document have been compiled on the basis of questions or concerns raised by providers from different states, during field-level interactions or orientation programs.